首页> 外文期刊>Headache >Rescue therapy for acute migraine, part 2: Neuroleptics, antihistamines, and others
【24h】

Rescue therapy for acute migraine, part 2: Neuroleptics, antihistamines, and others

机译:急性偏头痛的抢救治疗,第2部分:抗精神病药,抗组胺药及其他

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Objectives. This second portion of a 3-part series examines the relative effectiveness of headache treatment with neuroleptics, antihistamines, serotonin antagonists, valproate, and other drugs (octreotide, lidocaine, nitrous oxide, propofol, and bupivacaine) in the setting of an emergency department, urgent care center, or headache clinic. Methods. MEDLINE was searched using the terms "migraine" AND "emergency" AND "therapy" OR "treatment." Reports were from emergency department and urgent care settings and involved all routes of medication delivery. Reports from headache clinics were only included if medications were delivered by a parenteral route. Results. Prochlorperazine, promethazine, and metoclopramide, when used alone, were superior to placebo. Droperidol and prochlorperazine were superior or equal in efficacy to all other treatments, although they also have more side effects (especially akathisia). Metoclopramide was equivalent to prochlorperazine and, when combined with diphenhydramine, was superior in efficacy to triptans and non-steroidal anti-inflammatory drugs. Meperidine was inferior to chlorpromazine and equivalent to the other neuroleptics. The overall percentage of patients with pain relief after taking droperidol and prochlorperazine was equivalent to sumatriptan. Conclusions. Prochlorperazine and metoclopramide are the most frequently studied of the anti-migraine medications in the emergent setting, and the effectiveness of each is superior to placebo. Prochlorperazine is superior or equivalent to all other classes of medications in producing migraine pain relief. Dopamine antagonists, in general, appear to be equivalent for migraine pain relief to the migraine-"specific" medications sumatriptan and dihydroergotamine, although there are fewer studies involving the last two. Lack of comparisons to placebo and the frequent use of combination medications in treatment arms complicate the comparison of single agents to one other.
机译:目标。这个由三部分组成的系列文章的第二部分探讨了在急诊室使用抗精神病药,抗组胺药,5-羟色胺拮抗剂,丙戊酸盐和其他药物(奥曲肽,利多卡因,一氧化二氮,丙泊酚和布比卡因)进行头痛治疗的相对效果,紧急护理中心或头痛诊所。方法。使用术语“偏头痛”和“紧急”,“治疗”或“治疗”搜索MEDLINE。报告来自急诊部门和紧急护理场所,涉及所有药物输送途径。仅当通过肠胃外途径给药时,才包括头痛诊所的报告。结果。丙氯拉嗪,异丙嗪和甲氧氯普胺单独使用时,优于安慰剂。氟哌利多和氯丙嗪的疗效优于或等同于所有其他疗法,尽管它们还具有更多的副作用(特别是静坐症)。甲氧氯普胺等同于氯丙嗪,与苯海拉明联用时,其疗效优于曲普坦和非甾体类抗炎药。哌替啶不如氯丙嗪,等效于其他抗精神病药。服用氟哌利多和氯丙嗪后缓解疼痛的患者的总百分比与舒马普坦相当。结论。在紧急情况下,丙氯哌嗪和胃复安是抗偏头痛药物中研究最频繁的药物,每种药物的疗效均优于安慰剂。丙氯拉嗪在产生偏头痛止痛方面优于或等同于所有其他类别的药物。通常,多巴胺拮抗剂在缓解偏头痛方面似乎等同于偏头痛“特异”药物舒马曲坦和二氢麦角胺,尽管涉及后两者的研究较少。缺乏与安慰剂的比较以及治疗组中频繁使用联合药物使单一药物之间的比较变得复杂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号